Cambium Oncology
Pre-clinicalCambium Oncology is a team of scientists, drug development experts, cancer physicians, and business leaders united in a shared vision of treating cancer with a novel immunotherapeutic that targets the VIP signaling pathway.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Cambium Oncology is a team of scientists, drug development experts, cancer physicians, and business leaders united in a shared vision of treating cancer with a novel immunotherapeutic that targets the VIP signaling pathway.
Small MoleculesCell & Gene Therapy